Sort by
Refine Your Search
-
Listed
-
Field
-
on Quadruplex DNA structures. The fellowship is expected to start in 2025-08-15 or according to agreement. Application deadline is May 5th, 2025. Description of the project In addition to the classical double
-
based on structural changes and interactions. Possibly more than 50% of the human genome codes for non-coding RNA. These RNAs are ubiquitous among all life forms and the mechanisms how non-coding RNAs
-
models of interacting ecological and evolutionary (eco-evolutionary) processes. You will conceptualize and model the complexity in which ecological divergence and speciation drive an adaptive radiation
-
that will transform our understanding of pathogens, their interactions with hosts and the environment, and how they are transmitted through populations. Research will have a strong focus on computational
-
systems (e.g., Snakemake, Nextflow, or equivalent) Prior experience with interactive data visualization frameworks Experience analyzing spatial transcriptomics data (e.g. 10x Visium, image-based) Experience
-
around understanding how species interactions change over time and space, with a focus on butterfly caterpillar-plant interactions and development of phylogenetic methods. The EvonetsLab is supported by a
-
. Lappalainen and interactions with colleagues in the lab Opportunity to mentor students and junior researchers Close collaborations with the New York Genome Center and with the infrastructure platforms
-
preparations to investigate the interactions between malignant cells and their microenvironment using cutting-edge technologies. Qualifications Requirements for the employment are: You are required to hold a
-
Clinical Translational Postdoc Program with the purpose of promoting interaction between the SciLifeLab research environment and clinical research environments at Karolinska Institutet. The postdocs
-
are particularly interested in cancer-stroma interactions in pancreatic cancer. The long-term goal of our lab is to enable computer-aided design of precision cancer medicine. We are situated at the Science for Life